A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia

Tohru Araki, Teruhiko Yokoyama, Motoo Araki, Seiji Furuya

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We previously reported the effectiveness of loxoprofen sodium (loxoprofen), a non-steroidal anti-inflammatory drug, for patients with lower urinary tract symptoms (LUTS) complaining of nocturia. In this study, we explored the mechanism of loxoprofen in the treatment of nocturia. Fifty-six patients complaining of nocturia were enrolled. They took a single 60-mg tablet of loxoprofen at bedtime for 14 days. The effects of this treatment were assessed by bladder diaries. Nocturia improved (nocturia decreased ≥1 void/night) in 40 patients (71.4%). Nocturnal urine volume was reduced in 31 of 40 (77.5%) without nocturnal single-void volume increase. Nocturnal single-void volume increased in 4 of 40 (10.0%) without nocturnal urine volume reduction. Two of 40 (5.0%) demonstrated both nocturnal urine volume reduction and nocturnal single-void volume increase. Three (7.5%) were exceptions to the above. In conclusion, the main mechanism of loxoprofen is the reduction of nocturnal urine volume for the treatment of nocturia and the second mechanism is the increased bladder capacity. Copyright

Original languageEnglish
Article number3
JournalActa Medica Okayama
Volume62
Issue number6
Publication statusPublished - Dec 2008

Fingerprint

Nocturia
Anti-Inflammatory Agents
Urine
Pharmaceutical Preparations
Urinary Bladder
Tablets
Lower Urinary Tract Symptoms
loxoprofen
Therapeutics

Keywords

  • Loxoprofen
  • Nocturia
  • NSAID

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia. / Araki, Tohru; Yokoyama, Teruhiko; Araki, Motoo; Furuya, Seiji.

In: Acta Medica Okayama, Vol. 62, No. 6, 3, 12.2008.

Research output: Contribution to journalArticle

@article{10de35cfe18e45268f2b6e005df6455e,
title = "A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia",
abstract = "We previously reported the effectiveness of loxoprofen sodium (loxoprofen), a non-steroidal anti-inflammatory drug, for patients with lower urinary tract symptoms (LUTS) complaining of nocturia. In this study, we explored the mechanism of loxoprofen in the treatment of nocturia. Fifty-six patients complaining of nocturia were enrolled. They took a single 60-mg tablet of loxoprofen at bedtime for 14 days. The effects of this treatment were assessed by bladder diaries. Nocturia improved (nocturia decreased ≥1 void/night) in 40 patients (71.4{\%}). Nocturnal urine volume was reduced in 31 of 40 (77.5{\%}) without nocturnal single-void volume increase. Nocturnal single-void volume increased in 4 of 40 (10.0{\%}) without nocturnal urine volume reduction. Two of 40 (5.0{\%}) demonstrated both nocturnal urine volume reduction and nocturnal single-void volume increase. Three (7.5{\%}) were exceptions to the above. In conclusion, the main mechanism of loxoprofen is the reduction of nocturnal urine volume for the treatment of nocturia and the second mechanism is the increased bladder capacity. Copyright",
keywords = "Loxoprofen, Nocturia, NSAID",
author = "Tohru Araki and Teruhiko Yokoyama and Motoo Araki and Seiji Furuya",
year = "2008",
month = "12",
language = "English",
volume = "62",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "6",

}

TY - JOUR

T1 - A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia

AU - Araki, Tohru

AU - Yokoyama, Teruhiko

AU - Araki, Motoo

AU - Furuya, Seiji

PY - 2008/12

Y1 - 2008/12

N2 - We previously reported the effectiveness of loxoprofen sodium (loxoprofen), a non-steroidal anti-inflammatory drug, for patients with lower urinary tract symptoms (LUTS) complaining of nocturia. In this study, we explored the mechanism of loxoprofen in the treatment of nocturia. Fifty-six patients complaining of nocturia were enrolled. They took a single 60-mg tablet of loxoprofen at bedtime for 14 days. The effects of this treatment were assessed by bladder diaries. Nocturia improved (nocturia decreased ≥1 void/night) in 40 patients (71.4%). Nocturnal urine volume was reduced in 31 of 40 (77.5%) without nocturnal single-void volume increase. Nocturnal single-void volume increased in 4 of 40 (10.0%) without nocturnal urine volume reduction. Two of 40 (5.0%) demonstrated both nocturnal urine volume reduction and nocturnal single-void volume increase. Three (7.5%) were exceptions to the above. In conclusion, the main mechanism of loxoprofen is the reduction of nocturnal urine volume for the treatment of nocturia and the second mechanism is the increased bladder capacity. Copyright

AB - We previously reported the effectiveness of loxoprofen sodium (loxoprofen), a non-steroidal anti-inflammatory drug, for patients with lower urinary tract symptoms (LUTS) complaining of nocturia. In this study, we explored the mechanism of loxoprofen in the treatment of nocturia. Fifty-six patients complaining of nocturia were enrolled. They took a single 60-mg tablet of loxoprofen at bedtime for 14 days. The effects of this treatment were assessed by bladder diaries. Nocturia improved (nocturia decreased ≥1 void/night) in 40 patients (71.4%). Nocturnal urine volume was reduced in 31 of 40 (77.5%) without nocturnal single-void volume increase. Nocturnal single-void volume increased in 4 of 40 (10.0%) without nocturnal urine volume reduction. Two of 40 (5.0%) demonstrated both nocturnal urine volume reduction and nocturnal single-void volume increase. Three (7.5%) were exceptions to the above. In conclusion, the main mechanism of loxoprofen is the reduction of nocturnal urine volume for the treatment of nocturia and the second mechanism is the increased bladder capacity. Copyright

KW - Loxoprofen

KW - Nocturia

KW - NSAID

UR - http://www.scopus.com/inward/record.url?scp=58149462486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149462486&partnerID=8YFLogxK

M3 - Article

VL - 62

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 6

M1 - 3

ER -